Put together advanced neuroscience with signal-processing and machine-learning technologies and you get Neurosteer, the world’s first miniature, wearable continuous brain-activity monitor.
This Israeli invention, now in clinical trials in Israel, Europe and the United States, improves user experience compared to multiple-electrode electroencephalograph (EEG) and functional MRI (fMRI exams), explains Neurosteer CFO and VP business development Paul Weinberg.
“An EEG requires a half hour of placing electrodes, and fMRI involves getting into a big machine in a special controlled setting for 15 to 20 minutes with limited ability to stimulate the brain during recording,” says Weinberg.
“With Neurosteer, brain monitoring can be done on a 24/7 basis. It’s the EEG equivalent of a heartrate and glucose monitor that can be on continuously in a nonintrusive way while the patient carries out regular activities.”
Compared to fMRI – the current gold standard for brain activity screening and assessment – Neurosteer is inexpensive, portable and unobtrusive, requiring only an adhesive three-electrode strip placed on the forehead connected to a pocket-sized device that wirelessly transmits sensor data to a cloud-based HIPAA-compliant server.
The device can be used clinically for initial assessment of neurological disorders and then as part of a patient’s normal daily routine to see the effects of treatment. -- More....
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.